The practice pointers of the American College of Medical Genetics and Genomics (ACMG) and the National Society of Genetic Counselors (NSGC) are developed by members of the ACMG and NSGC to help medical geneticists, genetic counselors, and different health-care suppliers in making choices about applicable administration of genetic considerations, together with entry to and/or supply of providers. Each practice guideline focuses on a medical or practice-based concern and is the end result of a evaluate and evaluation of present skilled literature believed to be dependable.
As such, info and suggestions inside the ACMG and NSGC joint practice pointers replicate the present scientific and medical data at the time of publication, are present solely as of their publication date, and are topic to vary with out discover as advances emerge. In addition, variations in practice, which keep in mind the wants of the particular person affected person and the assets and limitations distinctive to the establishment or sort of practice, could warrant approaches, remedies, and/or procedures that differ from the suggestions outlined on this guideline. Therefore, these suggestions shouldn’t be construed as dictating an unique course of administration, nor does the use of such suggestions assure a specific consequence.
Genetic counseling practice pointers are by no means supposed to displace a health-care supplier’s finest medical judgment based mostly on the medical circumstances of a specific affected person or affected person inhabitants. Practice pointers are revealed by the ACMG or the NSGC for instructional and informational functions solely, and neither the ACMG nor the NSGC “approve” or “endorse” any particular strategies, practices, or sources of info.Cancer genetic session is a vital side of the care of people at elevated danger of a hereditary cancer syndrome.
Yet a number of affected person, clinician, and system-level boundaries hinder identification of people applicable for cancer genetics referral. Thus, the objective of this practice guideline is to current a single set of complete private and household historical past standards to facilitate identification and maximize applicable referral of at-risk people for cancer genetic session. To develop this guideline, a literature search for hereditary cancer susceptibility syndromes was carried out utilizing PubMed. In addition, GeneReviews and the National Comprehensive Cancer Network pointers have been reviewed when relevant.
When conflicting pointers have been recognized, the proof was ranked as follows: place papers from nationwide and skilled organizations ranked highest, adopted by consortium pointers, and then peer-reviewed publications from single establishments. The standards for cancer genetic session referral are offered in two codecs: (i) tables that checklist the tumor sort together with the standards that, if met, would warrant a referral for a cancer genetic session and (ii) an alphabetical checklist of the syndromes, together with a quick abstract of every and the rationale for the referral standards that have been chosen. Consider referral for a cancer genetic session in case your affected person or any of their first-degree family meet any of these referral standards.
The Shodair Medical Genetics Department–recent previous and future developments.
Philip Pallister and John Opitz laid the floor work for a novel genetic service mannequin in Montana that continues to flourish via ongoing help by the Montana Legislature, the Montana Department of Public Health and Human Services and the Shodair Foundation. At the coronary heart of the mannequin are medical and laboratory genetic specialists based mostly at Shodair Children’s Hospital in Helena offering genetic care for sufferers via outreach clinics. Clinical providers are supported by a state-of-the-art cytogenetics and molecular genetic laboratory as nicely a fetal genetic pathology program.
Over the years, the attain of common genetics clinics expanded to incorporate massive geographic areas together with northwest (Kalispell), west central (Missoula), southwest (Bozeman, Butte), north central (Great Falls), and south central Montana (Billings). Building on the basis of its world-renowned pioneers, the subsequent era of medical geneticists at Shodair carries the accountability of integrating genomic medication in the analysis and care of their sufferers, decreasing inequality of providers inside Montana and partnering with colleagues throughout specialties to develop a extra customized practice of medication.
The Pallister-Hall syndrome (PHS) was recognized and described as a selected entity in the late 1970s and early 1980s. Subsequently, many sufferers have been reported increasing the phenotype. Familial instances demonstrated variability and result in linkage and then gene identification. Mutations in the accountable gene, GLI3 are additionally identified to be concerned in a number of different issues. Genotype/phenotype correlations have led to wonderful mapping of GLI3 and the recognition that PHS is attributable to dominant damaging mutations in the center third of the gene.
Genetic variation and inhabitants differentiation in a medical herb Houttuynia cordata in China revealed by inter-simple sequence repeats (ISSRs).
Houttuynia cordata is a vital conventional Chinese herb with unresolved genetics and taxonomy, which result in potential issues in the conservation and utilization of the useful resource. Inter-simple sequence repeat (ISSR) markers have been used to evaluate the stage and distribution of genetic range in 226 people from 15 populations of H. cordata in China. ISSR evaluation revealed low genetic variations inside populations however excessive genetic differentiations amongst populations. This genetic construction most likely primarily displays the historic affiliation amongst populations.
 Total Protein - Human Tumor Tissue: Skin |
|
P1235218 |
Biochain |
1 mg |
EUR 357 |
 Total Protein - Human Tumor Tissue: Brain |
|
P1235035 |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Tumor Tissue: Colon |
|
P1235090 |
Biochain |
1 mg |
EUR 357 |
 Total Protein - Human Tumor Tissue: Liver |
|
P1235149 |
Biochain |
1 mg |
EUR 357 |
 Total Protein - Human Tumor Tissue: Ovary |
|
P1235183 |
Biochain |
1 mg |
EUR 357 |
 cDNA - Human Tumor Tissue: Nose |
|
C1235178-10 |
Biochain |
10 reactions |
EUR 301 |
 Total Protein - Human Tumor Tissue: Breast |
|
P1235086 |
Biochain |
1 mg |
EUR 357 |
 Total Protein - Human Tumor Tissue: Kidney |
|
P1235142 |
Biochain |
1 mg |
EUR 357 |
 Total Protein - Human Tumor Tissue: Oschea |
|
P1235182 |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Tumor Tissue: Rectum |
|
P1235206 |
Biochain |
1 mg |
EUR 357 |
 Total Protein - Human Tumor Tissue: Spleen |
|
P1235246 |
Biochain |
1 mg |
EUR 357 |
 Total Protein - Human Tumor Tissue: Testis |
|
P1235260 |
Biochain |
1 mg |
EUR 357 |
 Total Protein - Human Tumor Tissue: Thymus |
|
P1235264 |
Biochain |
1 mg |
EUR 357 |
 Total Protein - Human Tumor Tissue: Tonsil |
|
P1235268 |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Tumor Tissue: Ureter |
|
P1235273 |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Tumor Tissue: Uterus |
|
P1235274 |
Biochain |
1 mg |
EUR 357 |
 Total Protein - Human Tumor Tissue: Adrenal |
|
P1235004 |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Tumor Tissue: Bladder |
|
P1235010 |
Biochain |
1 mg |
EUR 357 |
 Total Protein - Human Tumor Tissue: Parotid |
|
P1235190 |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Tumor Tissue: Pharynx |
|
P1235199 |
Biochain |
1 mg |
EUR 357 |
 Total Protein - Human Tumor Tissue: Stomach |
|
P1235248 |
Biochain |
1 mg |
EUR 357 |
 Total Protein - Human Tumor Tissue: Thyroid |
|
P1235265 |
Biochain |
1 mg |
EUR 357 |
 Total Protein - Human Tumor Tissue: Prostate |
|
P1235201 |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Tumor Tissue: Lymphoma |
|
P1235161 |
Biochain |
1 mg |
EUR 357 |
 Total Protein - Human Tumor Tissue: Pancreas |
|
P1235188 |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Tumor Tissue: Melanoma |
|
P1235218A |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Tumor Tissue: Esophagus |
|
P1235106 |
Biochain |
1 mg |
EUR 357 |
 Total Protein - Human Tumor Tissue: Gallbladder |
|
P1235118 |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Tumor Tissue: Parathyroid |
|
P1235189 |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Tumor Tissue: Neurofibroma |
|
P1235177A |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Tumor Tissue: Neurilemmoma |
|
P1235177B |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Tumor Tissue: Leiomyosarcoma |
|
P1235172 |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Tumor Tissue: Synoviosarcoma |
|
P1235257 |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Tumor Tissue: Skeletal Muscle |
|
P1235171 |
Biochain |
1 mg |
EUR 357 |
 Total Protein - Human Tumor Tissue: Small Intestine |
|
P1235226 |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Tumor Tissue: Lymphoma, Hodgkin's |
|
P1235161A |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Tumor Tissue: Lymphoma, Non-Hodgkin's |
|
P1235161B |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Tumor Tissue: Small Intestine: Duodenum |
|
P1235101 |
Biochain |
1 mg |
EUR 542 |
 Total RNA - Human Tumor Tissue: Bone |
|
R1235023-10 |
Biochain |
10 ug |
EUR 480 |
 Total RNA - Human Tumor Tissue: Lung |
|
R1235152-50 |
Biochain |
50 ug |
EUR 480 |
 Total RNA - Human Tumor Tissue: Colon |
|
R1235090-50 |
Biochain |
50 ug |
EUR 480 |
 Total RNA - Human Tumor Tissue: Liver |
|
R1235149-50 |
Biochain |
50 ug |
EUR 480 |
 Total RNA - Human Tumor Tissue: Ovary |
|
R1235183-10 |
Biochain |
10 ug |
EUR 480 |
 Total RNA - Human Tumor Tissue: Breast |
|
R1235086-50 |
Biochain |
50 ug |
EUR 480 |
 Total RNA - Human Tumor Tissue: Kidney |
|
R1235142-50 |
Biochain |
50 ug |
EUR 480 |
 Total RNA - Human Tumor Tissue: Rectum |
|
R1235206-50 |
Biochain |
50 ug |
EUR 480 |
 Total RNA - Human Tumor Tissue: Thymus |
|
R1235264-10 |
Biochain |
10 ug |
EUR 480 |
 Total RNA - Human Tumor Tissue: Tonsil |
|
R1235268-10 |
Biochain |
10 ug |
EUR 480 |
 Total RNA - Human Tumor Tissue: Uterus |
|
R1235274-50 |
Biochain |
50 ug |
EUR 480 |
: Colon) Matched Pair - Total Protein - Human Primary Tumor and Metastatic Tumor Tissue (PM): Colon |
|
P8235090-PM |
Biochain |
0.2 mg x2 |
EUR 1431 |
: Liver) Matched Pair - Total Protein - Human Primary Tumor and Metastatic Tumor Tissue (PM): Liver |
|
P8235149-PM |
Biochain |
0.2 mg x2 |
EUR 1431 |
: Lung) Matched Pair - Total Protein - Human Primary Tumor and Metastatic Tumor Tissue (PM): Lung |
|
P8235152-PM |
Biochain |
0.2 mg x2 |
EUR 1431 |
 Total RNA - Human Tumor Tissue: Adrenal |
|
R1235004-10 |
Biochain |
10 ug |
EUR 480 |
 Total RNA - Human Tumor Tissue: Bladder |
|
R1235010-10 |
Biochain |
10 ug |
EUR 480 |
 Total RNA - Human Tumor Tissue: Parotid |
|
R1235190-10 |
Biochain |
10 ug |
EUR 480 |
 Total RNA - Human Tumor Tissue: Stomach |
|
R1235248-50 |
Biochain |
50 ug |
EUR 480 |
 Total RNA - Human Tumor Tissue: Thyroid |
|
R1235265-50 |
Biochain |
50 ug |
EUR 480 |
 Total RNA - Human Tumor Tissue: Melanoma |
|
R1235218A-10 |
Biochain |
10 ug |
EUR 480 |
: Breast) Matched Pair - Total Protein - Human Primary Tumor and Metastatic Tumor Tissue (PM): Breast |
|
P8235086-PM |
Biochain |
0.2 mg x2 |
EUR 1431 |
: Kidney) Matched Pair - Total Protein - Human Primary Tumor and Metastatic Tumor Tissue (PM): Kidney |
|
P8235142-PM |
Biochain |
0.2 mg x2 |
EUR 1431 |
: Rectum) Matched Pair - Total Protein - Human Primary Tumor and Metastatic Tumor Tissue (PM): Rectum |
|
P8235206-PM |
Biochain |
0.2 mg x2 |
EUR 1431 |
: Stomach) Matched Pair - Total Protein - Human Primary Tumor and Metastatic Tumor Tissue (PM): Stomach |
|
P8235248-PM |
Biochain |
0.2 mg x2 |
EUR 1431 |
 Total RNA - Human Tumor Tissue: Esophagus |
|
R1235106-50 |
Biochain |
50 ug |
EUR 480 |
 Total RNA - Human Tumor Tissue: Synoviosarcoma |
|
R1235257-10 |
Biochain |
10 ug |
EUR 480 |
 Total RNA - Human Tumor Tissue: Colon, sigmoid |
|
R1235095-50 |
Biochain |
50 ug |
EUR 480 |
 Total RNA - Human Tumor Tissue: Small Intestine |
|
R1235226-10 |
Biochain |
10 ug |
EUR 480 |
: Lung) Matched Pair - Total Protein - Human Primary Tumor and Normal Tissue (PP): Lung |
|
P8235152-PP |
Biochain |
0.2 mg x2 |
EUR 716 |
: Colon) Matched Pair - Total Protein - Human Primary Tumor and Normal Tissue (PP): Colon |
|
P8235090-PP |
Biochain |
0.2 mg x2 |
EUR 716 |
: Liver) Matched Pair - Total Protein - Human Primary Tumor and Normal Tissue (PP): Liver |
|
P8235149-PP |
Biochain |
0.2 mg x2 |
EUR 716 |
: Breast) Matched Pair - Total Protein - Human Primary Tumor and Normal Tissue (PP): Breast |
|
P8235086-PP |
Biochain |
0.2 mg x2 |
EUR 716 |
: Kidney) Matched Pair - Total Protein - Human Primary Tumor and Normal Tissue (PP): Kidney |
|
P8235142-PP |
Biochain |
0.2 mg x2 |
EUR 716 |
: Rectum) Matched Pair - Total Protein - Human Primary Tumor and Normal Tissue (PP): Rectum |
|
P8235206-PP |
Biochain |
0.2 mg x2 |
EUR 716 |
: Stomach) Matched Pair - Total Protein - Human Primary Tumor and Normal Tissue (PP): Stomach |
|
P8235248-PP |
Biochain |
0.2 mg x2 |
EUR 716 |
 Human Adipose Tissue Total Protein* |
|
HT-103 |
Zyagen |
0.1mg |
EUR 229 |
 Matched Pair - Total RNA - Human Primary and Metastatic Tumor Tissue: Lung |
|
R8235152-PM-10 |
Biochain |
2x10 ug |
EUR 773 |
 Matched Pair - Total RNA - Human Primary and Metastatic Tumor Tissue: Colon |
|
R8235090-PM-10 |
Biochain |
2x10 ug |
EUR 773 |
 Matched Pair - Total RNA - Human Primary and Metastatic Tumor Tissue: Liver |
|
R8235149-PM-10 |
Biochain |
2x10 ug |
EUR 773 |
 Matched Pair - Total RNA - Human Primary and Metastatic Tumor Tissue: Breast |
|
R8235086-PM-10 |
Biochain |
2x10 ug |
EUR 773 |
 Matched Pair - Total RNA - Human Primary and Metastatic Tumor Tissue: Kidney |
|
R8235142-PM-10 |
Biochain |
2x10 ug |
EUR 773 |
 Matched Pair - Total RNA - Human Primary and Metastatic Tumor Tissue: Rectum |
|
R8235206-PM-10 |
Biochain |
2x10 ug |
EUR 773 |
 Matched Pair - Total RNA - Human Primary and Metastatic Tumor Tissue: Stomach |
|
R8235248-PM-10 |
Biochain |
2x10 ug |
EUR 773 |
 Matched Pair - Total RNA - Human Primary Tumor and Normal Tissue: Lung |
|
R8235152-PP-10 |
Biochain |
2x10 ug |
EUR 500 |
 Matched Pair - Total RNA - Human Primary Tumor and Normal Tissue: Colon |
|
R8235090-PP-10 |
Biochain |
2x10 ug |
EUR 500 |
 Matched Pair - Total RNA - Human Primary Tumor and Normal Tissue: Liver |
|
R8235149-PP-10 |
Biochain |
2x10 ug |
EUR 500 |
 Matched Pair - Total RNA - Human Primary Tumor and Normal Tissue: Breast |
|
R8235086-PP-10 |
Biochain |
2x10 ug |
EUR 500 |
 Matched Pair - Total RNA - Human Primary Tumor and Normal Tissue: Kidney |
|
R8235142-PP-10 |
Biochain |
2x10 ug |
EUR 500 |
 Matched Pair - Total RNA - Human Primary Tumor and Normal Tissue: Rectum |
|
R8235206-PP-10 |
Biochain |
2x10 ug |
EUR 500 |
 Matched Pair - Total RNA - Human Primary Tumor and Normal Tissue: Stomach |
|
R8235248-PP-10 |
Biochain |
2x10 ug |
EUR 500 |
 Total Protein - Human Adult Normal Tissue: Lung |
|
P1234152 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Skin |
|
P1234218 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Brain |
|
P1234035 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Cecum |
|
P1234089 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Colon |
|
P1234090 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Heart |
|
P1234122 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Liver |
|
P1234149 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Ovary |
|
P1234183 |
Biochain |
1 mg |
EUR 887 |
 Total Protein - Human Adult Normal Tissue: Penis |
|
P1234194 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Theca |
|
P1234261 |
Biochain |
1 mg |
EUR 404 |
 Total Protein - Human Adult Normal Tissue: Breast |
|
P1234086 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Kidney |
|
P1234142 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Rectum |
|
P1234206 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Spleen |
|
P1234246 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Testis |
|
P1234260 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Throat |
|
P1234263 |
Biochain |
1 mg |
EUR 404 |
 Total Protein - Human Adult Normal Tissue: Thymus |
|
P1234264 |
Biochain |
1 mg |
EUR 591 |
 Total Protein - Human Adult Normal Tissue: Tongue |
|
P1234267 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Tonsil |
|
P1234268 |
Biochain |
1 mg |
EUR 460 |
 Total Protein - Human Adult Normal Tissue: Ureter |
|
P1234273 |
Biochain |
1 mg |
EUR 590 |
 Total Protein - Human Adult Normal Tissue: Uterus |
|
P1234274 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Vagina |
|
P1234283 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Adipose |
|
P1234003 |
Biochain |
1 mg |
EUR 404 |
 Total Protein - Human Adult Normal Tissue: Adrenal |
|
P1234004 |
Biochain |
1 mg |
EUR 404 |
 Total Protein - Human Adult Normal Tissue: Bladder |
|
P1234010 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Trachea |
|
P1234160 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Parotid |
|
P1234190 |
Biochain |
1 mg |
EUR 404 |
 Total Protein - Human Adult Normal Tissue: Stomach |
|
P1234248 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Thyroid |
|
P1234265 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Prostate |
|
P1234201 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Appendix |
|
P1234006 |
Biochain |
1 mg |
EUR 404 |
 Total Protein - Human Adult Normal Tissue: Pancreas |
|
P1234188 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Placenta |
|
P1234200 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Esophagus |
|
P1234106 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Diaphragm |
|
P1234169 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Diabetic Diseased Tissue: Lung |
|
P1236152Dia |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Diabetic Diseased Tissue: Skin |
|
P1236218Dia |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Adult Normal Tissue: Epididymis |
|
P1234105 |
Biochain |
1 mg |
EUR 404 |
 Total Protein - Human Diabetic Diseased Tissue: Brain |
|
P1236035Dia |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Diabetic Diseased Tissue: Colon |
|
P1236090Dia |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Diabetic Diseased Tissue: Heart |
|
P1236122Dia |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Diabetic Diseased Tissue: Liver |
|
P1236149Dia |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Adult Normal Tissue: Gallbladder |
|
P1234118 |
Biochain |
1 mg |
EUR 404 |
 Total Protein - Human Adult Normal Tissue: Parathyroid |
|
P1234189 |
Biochain |
1 mg |
EUR 822 |
 Total Protein - Human Diabetic Diseased Tissue: Kidney |
|
P1236142Dia |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Diabetic Diseased Tissue: Spleen |
|
P1236246Dia |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Diabetic Diseased Tissue: Adrenal |
|
P1236004Dia |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Diabetic Diseased Tissue: Stomach |
|
P1236248Dia |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Adult Normal Tissue: Whole Eye |
|
P1234108 |
Biochain |
1 mg |
EUR 822 |
 Total Protein - Human Diabetic Diseased Tissue: Pancreas |
|
P1236188Dia |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Adult Normal Tissue: Brain: Pons |
|
P1234071 |
Biochain |
1 mg |
EUR 216 |
 Total Protein - Human Adult Normal Tissue: Lymph Node |
|
P1234161 |
Biochain |
1 mg |
EUR 404 |
 Total Protein - Human Diabetic Diseased Tissue: Esophagus |
|
P1236106Dia |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Human Adult Normal Tissue: Spinal Cord |
|
P1234234 |
Biochain |
1 mg |
EUR 404 |
 Dog Adipose Tissue Total Protein |
|
DT-103 |
Zyagen |
0.5mg |
EUR 176 |
Genetic cluster evaluation confirmed that the basal clade consists of populations from Southwest China, and the different populations have steady and eastward distributions. The construction of genetic range in H. cordata demonstrated that this species might need survived in Southwest China throughout the glacial age, and subsequently skilled an japanese postglacial growth. Based on the outcomes of genetic evaluation, it was proposed that as many as attainable focused populations for conservation be included.
